Former MMV Board member recognised at the World Government Summit 2017 in Dubai
Awa Marie Coll-Seck receives Best Minister Award
CEO will lead new team to support attainment of the global goals for malaria
Save the date: Tuesday, 25 April │ Swiss Malaria Group photo exhibition
Our 15th Call for proposals closes Friday, 24 March.
Doing research on malaria or NTDs? Request the Pathogen Box, free of charge.
of Eurartesim® (dihydroartemisinin-piperaquine), co-developed with Sigma-Tau, distributed in two ground-breaking mass drug administration pilots in Zambia and Mozambique
in clinical development prioritizing eradication and treatment for vulnerable populations including children and pregnant women
across 1,650 health-care facilities in six African countries trained to administer injectable artesunate for severe malaria